RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 137 filers reported holding RELAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,227,257 | -22.7% | 6,923,574 | +15.4% | 6.44% | -2.1% |
| Q2 2023 | $75,342,089 | -19.7% | 5,998,574 | +5.3% | 6.58% | -14.8% |
| Q1 2023 | $93,855,514 | +107.3% | 5,698,574 | +88.0% | 7.73% | +120.4% |
| Q4 2022 | $45,277,881 | -56.8% | 3,030,648 | -35.3% | 3.51% | -49.0% |
| Q3 2022 | $104,768,000 | +53.7% | 4,683,432 | +15.1% | 6.88% | +19.4% |
| Q2 2022 | $68,149,000 | -41.0% | 4,068,574 | +5.5% | 5.76% | +11.3% |
| Q1 2022 | $115,448,000 | -2.5% | 3,857,253 | 0.0% | 5.18% | +55.0% |
| Q4 2021 | $118,456,000 | +2.4% | 3,857,253 | +5.1% | 3.34% | +16.0% |
| Q3 2021 | $115,670,000 | -6.3% | 3,668,574 | +8.7% | 2.88% | -8.2% |
| Q2 2021 | $123,493,000 | +5.8% | 3,375,058 | 0.0% | 3.14% | -9.8% |
| Q1 2021 | $116,676,000 | -26.3% | 3,375,058 | -11.4% | 3.48% | -25.9% |
| Q4 2020 | $158,298,000 | -2.4% | 3,808,894 | 0.0% | 4.69% | -35.4% |
| Q3 2020 | $162,221,000 | – | 3,808,894 | – | 7.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |